Mangaluru, Apr 25, 2019: The present translational research in India will not be able to achieve its objectives unless important changes in education and training modules are addressed. The T1 (bench to bedside) and T2 (bedside to bench) phases of translational research are complimentary and need important resources mostly financial, that requires quality collaborations between clinical and molecular scientists.
It is important to note that in India, a lot of emphasis was given to develop physician-scientists (T2) and despite all the euphoria, innovations in the biomedical field have been negligible. The T1 cycle that exploits the expertise of majority research scientists outside the medical institutes like universities and academic institutions have not been well integrated. It is extremely important to link molecular networks with clinical observations to complete the T1-T2 cycle.
Especially in a country as big as ours and low investments in research, more emphasis must be given to biomedical related problems where the scientific community works in tandem with clinicians. In this direction, Institute for Applied Research and Innovation (InARI) and NITTE (Deemed to be University) have joined hands by signing MoU on 9.4.2019 to create training, education and research programs apt for Indian healthcare needs. InARI focuses on applied research with direct benefits to society and healthcare is its top priority. By signing this MoU with NITTE (Deemed to be University), a premier medical institute, a new chapter has begun in translational research for India.